← Leaderboards
Bonnie F Sloane
Wayne State University
$8,629,575
Attributed
$9,598,407
Total exposure
15
Grants
11
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–14$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
Funding mix
By agency
NIH$9,598,407 · 15
By mechanism
R01$6,970,767 · 3
U54$1,296,415 · 8
P30$793,033 · 2
R21$358,702 · 1
R03$179,490 · 1
Top collaborators
- Raymond R Mattingly11 shared
Most similar at Wayne State University
Same institution · by research overlap
- Raymond R Mattingly$1,985,660
- Jun Li$7,226,441
- Rafael A. Fridman$9,123,443
- Felix Fernandez-Madrid$1,891,907
Others in their field
Top investigators on “Cell Line”
- David Heimbrook · Leidos Biomedical Research, Inc.$236,973,333
- Dennis R. Burton · Scripps Research Institute$203,685,614
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$177,001,772
- John M Lachin · George Washington University$118,672,444
- David M Nathan · Massachusetts Institute Of Technology$118,672,444
- Fred M Gordin · Social And Scientific Systems, Inc.$82,802,056
Research focus
Cell LineProteolysisPeptide HydrolasesPremalignantTumorCell TypeIn VivoCellsCoculture TechniquesMacrophageFibroblastsIn VitroPathway InteractionsCathepsinsMalignant NeoplasmsMatrix MetalloproteinasesInhibitor/AntagonistCysteine ProteaseNeoplastic CellBreastMammary GlandTherapeutic InterventionCarcinomaImplantation
Grant awards (51)
4D Microfluidic Platforms for Targeting Breast Cancer:Lymphatic Interactions$160,342
R21 · FY2014 · CA · contact PI
4D Microfluidic Platforms for Targeting Breast Cancer:Lymphatic Interactions$198,360
R21 · FY2013 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$54,624
R01 · FY2013 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$304,550
R01 · FY2012 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$92,060
R01 · FY2012 · CA · contact PI
Inflammatory Breast Cancer: Factors Contributing to Dissemination$57,470
R03 · FY2012 · TW · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$305,287
R01 · FY2011 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$76,880
R01 · FY2011 · CA · contact PI
Inflammatory Breast Cancer: Factors Contributing to Dissemination$57,470
R03 · FY2011 · TW · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$51,630
R01 · FY2011 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$317,972
R01 · FY2010 · CA · contact PI
Inflammatory Breast Cancer: Factors Contributing to Dissemination$64,550
R03 · FY2010 · TW · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$56,697
R01 · FY2010 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$314,155
R01 · FY2009 · CA · contact PI
Cathepsins in Malignant Progression$304,248
R01 · FY2009 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$53,470
R01 · FY2009 · CA · contact PI
Proteases Program$27,191
P30 · FY2009 · CA · contact PI
Cathepsins in Malignant Progression$337,713
R01 · FY2008 · CA · contact PI
Proteolytic Pathways in Progression of Pre-Malignant Breast Disease$310,340
R01 · FY2008 · CA · contact PI
CORE 3B: INFRASTRUCTURE IMAGING$214,368
U54 · FY2008 · RR · contact PI
CORE 2 DB4: PROTEASE PATHWAYS IN CAVEOLAE$116,499
U54 · FY2008 · RR · contact PI
Proteases Program$27,709
P30 · FY2008 · CA · contact PI
Cathepsins in Malignant Progression$371,183
R01 · FY2007 · CA · contact PI
CORE 3B: INFRASTRUCTURE IMAGING$205,444
U54 · FY2007 · RR · contact PI
CORE 2 DB4: PROTEASE PATHWAYS IN CAVEOLAE$111,648
U54 · FY2007 · RR · contact PI
Proteases Program$27,932
P30 · FY2007 · CA · contact PI
Cathepsins in Malignant Progression$313,334
R01 · FY2006 · CA · contact PI
CORE 3B: INFRASTRUCTURE IMAGING$221,444
U54 · FY2006 · RR · contact PI
CORE 2 DB4: PROTEASE PATHWAYS IN CAVEOLAE$120,345
U54 · FY2006 · RR · contact PI
Proteases Program$15,061
P30 · FY2006 · CA · contact PI
Cathepsins in Malignant Progression$314,373
R01 · FY2005 · CA
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS$293,100
R01 · FY2005 · CA
CORE 3B: INFRASTRUCTURE IMAGING$198,689
U54 · FY2005 · RR
CORE 2 DB4: PROTEASE PATHWAYS IN CAVEOLAE$107,978
U54 · FY2005 · RR
Proteases Program$14,622
P30 · FY2005 · CA
CATHEPSINS IN MALIGNANT PROGRESSION$341,039
R01 · FY2004 · CA
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS$293,590
R01 · FY2004 · CA
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS$576,108
R01 · FY2003 · CA
CATHEPSINS IN MALIGNANT PROGRESSION$371,437
R01 · FY2003 · CA
CATHEPSINS IN MALIGNANT PROGRESSION$363,752
R01 · FY2002 · CA
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS$298,000
R01 · FY2002 · CA
CORE-- CELL IMAGING$174,086
P30 · FY2002 · ES
PROTEASE$0
P30 · FY2002 · CA
ABERRANT REGULATION OF CATHEPSIN B EXPRESSION IN TUMORS$289,180
R01 · FY2001 · CA
CATHEPSINS IN MALIGNANT PROGRESSION$280,903
R01 · FY2001 · CA
CORE-- CELL IMAGING$174,086
P30 · FY2001 · ES
PROTEASE$0
P30 · FY2001 · CA
PROTEASE$0
P30 · FY2001 · CA
CATHEPSINS IN MALIGNANT PROGRESSION$285,142
R01 · FY2000 · CA
CORE-- CELL IMAGING$174,086
P30 · FY2000 · ES
CORE-- CELL IMAGING$158,260
P30 · FY2000 · ES